Chloride Homeostasis Critically Regulates Synaptic NMDA Receptor Activity in Neuropathic Pain  by Li, Lingyong et al.
ReportChloride Homeostasis Critically Regulates Synaptic
NMDA Receptor Activity in Neuropathic PainGraphical AbstractHighlightsd Intrathecal delivery of KCC2 in lentiviral vectors eliminates
neuropathic pain
d KCC2 gene transfer restores spinal cord KCC2 function
impaired by nerve injury
d KCC2 ectopic expression counteracts NKCC1 activity in
primary sensory neurons
d Restoring Cl homeostasis normalizes spinal cord synaptic
NMDA receptor activityLi et al., 2016, Cell Reports 15, 1376–1383
May 17, 2016 ª 2016 The Author(s)
http://dx.doi.org/10.1016/j.celrep.2016.04.039Authors
Lingyong Li, Shao-Rui Chen, Hong Chen,
Lei Wen, Walter N. Hittelman, Jing-Dun
Xie, Hui-Lin Pan
Correspondence
huilinpan@mdanderson.org
In Brief
Li et al. find that spinal KCC2 gene
transfer induces sustained KCC2
expression and restores chloride
homeostasis disrupted by nerve injury in
both dorsal horn and primary sensory
neurons. KCC2 gene transfer completely
and persistently eliminates neuropathic
pain and normalizes pre- and
postsynaptic NMDA receptor activity
increased by nerve injury.
Cell Reports
ReportChloride Homeostasis Critically Regulates Synaptic
NMDA Receptor Activity in Neuropathic Pain
Lingyong Li,1,4 Shao-Rui Chen,1,4 Hong Chen,1 Lei Wen,1 Walter N. Hittelman,2 Jing-Dun Xie,1,3 and Hui-Lin Pan1,*
1Center for Neuroscience and Pain Research, Department of Anesthesiology and Perioperative Medicine
2Department of Experimental Therapeutics
The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
3Department of Anesthesiology, Sun Yat-Sen University Cancer Center, Guangzhou, Guangdong 510060, China
4Co-first author
*Correspondence: huilinpan@mdanderson.org
http://dx.doi.org/10.1016/j.celrep.2016.04.039SUMMARY
Chronic neuropathic pain is a debilitating condition
that remains difficult to treat. Diminished synaptic in-
hibition by GABA and glycine and increased NMDA
receptor (NMDAR) activity in the spinal dorsal horn
are key mechanisms underlying neuropathic pain.
However, the reciprocal relationship between synap-
tic inhibition and excitation in neuropathic pain is un-
clear. Here, we show that intrathecal delivery of K+-
Cl cotransporter-2 (KCC2) using lentiviral vectors
produces a complete and long-lasting reversal of
pain hypersensitivity induced by nerve injury. KCC2
gene transfer restores Cl homeostasis disrupted
by nerve injury in both spinal dorsal horn and primary
sensory neurons. Remarkably, restoring Cl homeo-
stasis normalizes both presynaptic and postsynaptic
NMDAR activity increased by nerve injury in the
spinal dorsal horn. Our findings indicate that nerve
injury recruits NMDAR-mediated signaling pathways
through the disruption of Cl homeostasis in spinal
dorsal horn and primary sensory neurons. Lentiviral
vector-mediated KCC2 expression is a promising
gene therapy for the treatment of neuropathic pain.
INTRODUCTION
Chronic neuropathic pain is a major, debilitating clinical problem
that remains difficult to treat. Because all of the existing analge-
sics for treating neuropathic pain, including anti-depressants,
opioids, and gabapentinoids, have limited efficacy and often
produce intolerable adverse effects (Finnerup et al., 2015; Som-
mer, 2015), the development of highly effective treatments with
minimal off-target effects is urgently needed. GABAergic and
glycinergic interneurons, which are densely distributed in the
spinal dorsal horn, are the basis of the gate control theory of
pain (Melzack and Wall, 1965). Normal synaptic inhibition by
GABA and glycine critically depends on the coordinated activ-
ities of two functionally distinct cation-chloride cotransporters:
Na+-K+-2Cl cotransporter-1 (NKCC1) and K+-Cl cotrans-
porter-2 (KCC2). KCC2, encoded by Slc12a5, is the dominant1376 Cell Reports 15, 1376–1383, May 17, 2016 ª 2016 The Author(s
This is an open access article under the CC BY-NC-ND license (http://neuronal Cl extrusion mechanism, whereas NKCC1 normally
raises intracellular Cl levels above equilibrium and opposes
the action of KCC2 (Payne et al., 1996; Rivera et al., 1999).
Thus, changing the intracellular Cl concentration can pro-
foundly alter the strength and polarity of GABA- or glycine-medi-
ated responses. Neuropathic pain caused by peripheral nerve
damage, spinal cord injury, diabetic neuropathy, and chemo-
therapy is associated with reduced KCC2 activity or increased
NKCC1 activity in spinal dorsal horn neurons (Boulenguez
et al., 2010; Chen et al., 2014d; Coull et al., 2003; Jolivalt et al.,
2008; Zhou et al., 2012). Nerve injury also increases NKCC1
phosphorylation and activity in dorsal root ganglion (DRG) neu-
rons to reduce presynaptic inhibition (Chen et al., 2014a; Mo`dol
et al., 2014). However, it is unclear whether and to what extent
restoring Cl homeostasis at the spinal cord level leads to
long-term reduction in neuropathic pain.
In addition to diminished synaptic inhibition, increased
N-methyl D-aspartate receptor (NMDAR) activity in the spinal
dorsal horn plays a key role in the development of neuropathic
pain (Chaplan et al., 1997; Chen et al., 2014c). Peripheral nerve
injury increases spinal NMDAR activity, which impairs synaptic
inhibition through calpain-mediated KCC2 proteolysis (Zhou
et al., 2012).However, it is unclearwhether the loss ofCl-depen-
dent synaptic inhibition accounts for the increasedNMDARactiv-
ity in the spinal dorsal horn induced by nerve injury. To determine
whether restoringClhomeostasis reduces the synapticNMDAR
activity in the spinal dorsal horn that is increased by nerve injury
and, therefore, relieves neuropathic pain, we studied intrathecal
KCC2gene delivery in ratmodels. Gene therapy offers the poten-
tial to correct these sustained abnormal signaling pathways and
is well suited for treating chronic pain. Lentiviral vectors in partic-
ular have the advantages of long-term transgene expression, low
immunogenicity, and the ability to accommodate larger trans-
genes and transduce nondividing cells such as mature neurons
(Nayak and Herzog, 2010; Wong et al., 2006).
We show that intrathecal KCC2 gene transfer is highly efficient
at restoring Cl homeostasis in both spinal dorsal horn and DRG
neurons and produces complete and long-lasting relief of neuro-
pathic pain. Strikingly, KCC2 gene transfer normalizes, at both
pre- and postsynaptic sites, spinal NMDAR activity increased
by nerve injury. Our study provides direct evidence that disrup-
ted neuronal Cl homeostasis plays a critical role in potentiated
synaptic NMDAR activity in neuropathic pain. This information)
creativecommons.org/licenses/by-nc-nd/4.0/).
Figure 1. Intrathecal KCC2 Gene Transfer Eliminates Nerve Injury-Induced Pain Hypersensitivity
(A) Schematics of lentiviral vectors engineered to express KCC2-GFP (KCC2 vector) or GFP alone (control vector) (long terminal repeats: LTR and cytomega-
lovirus promoter: CMV).
(B) Experimental design for testing the effects of the KCC2 vector using a rat neuropathic pain model.
(C) Time course of changes in the mechanical nociceptive threshold after intrathecal injection of the KCC2 (n = 8 rats) or control (n = 7 rats) vector in SNL rats
(baseline: BL) ***p < 0.001 compared with the corresponding value in the control vector group) (two-way ANOVA analysis followed by Tukey’s post hoc test).
(D) Time course of changes in the tactile withdrawal threshold after intrathecal injection of the KCC2 (n = 8 rats) or control (n = 7 rats) vector in SNL rats (baseline:
BL) (**p < 0.01 and ***p < 0.001 compared with the corresponding value in the control vector group) (two-way ANOVA analysis followed by Tukey’s post hoc test).
The data are presented as means ± SEM.
(E) Effect of intrathecal injection of the KCC2 (n = 8 rats) or control (n = 7 rats) vector on the mechanical nociceptive threshold in sham control rats. The data are
presented as means ± SEM.
(F) Effect of intrathecal injection of the KCC2 (n = 8 rats) or control (n = 7 rats) vector on the tactile threshold in sham control rats. The data are presented as
means ± SEM.significantly advances our understanding of homeostatic synap-
tic plasticity and suggests a strategy for treating chronic neuro-
pathic pain.
RESULTS
Intrathecal KCC2Gene Transfer Abolishes Nerve Injury-
Induced Pain Hypersensitivity
Nerve injury decreases the protein level and function of KCC2 in
spinal dorsal horn neurons, thereby contributing to the loss ofsynaptic inhibition and the development of neuropathic pain
(Coull et al., 2003; Zhou et al., 2012). We constructed lentiviral
vectors encoding rat KCC2 protein (KCC2 vector) or enhanced
GFP (control vector) (Figure 1A). To determine whether KCC2
gene transfer at the spinal cord level is sufficient to reduce
pain hypersensitivity induced by nerve injury, we used spinal
nerve ligation (SNL) in rats, a commonly used animal model of
neuropathic pain (Chaplan et al., 1994; Kim and Chung, 1992).
We performed intrathecal injection of the KCC2 or control vector
2 weeks after SNL surgery. Tactile allodynia, measured with vonCell Reports 15, 1376–1383, May 17, 2016 1377
Frey filaments, and mechanical hyperalgesia, tested with a
nociceptive pressure stimulus, were measured at baseline
before SNL, at the time of intrathecal vector injection, and every
2–3 days for 6 weeks after vector injection (Figure 1B).
Intrathecal injection of the control vector had no significant ef-
fect on tactile allodynia or mechanical hyperalgesia in SNL rats
over the course of 8 weeks (Figures 1C and 1D). By contrast, a
single intrathecal injection of the KCC2 vector abolished me-
chanical hyperalgesia in all rats. At 2weeks after the KCC2 vector
delivery, the nociceptive threshold had already returned to the
pre-SNL (baseline) level, and this effect lasted for at least another
6 weeks (Figure 1C). KCC2 vector injection also fully reversed the
thermal hypersensitivity of SNL rats (Figure S1). To our surprise,
intrathecal injection of KCC2 vectors only gradually reduced
tactile allodynia over the first 5 weeks. Nevertheless, the tactile
threshold of treated SNL rats completely returned to the pre-
SNL (baseline) level 6 weeks after KCC2 vector injection; the
effect lasted for at least another 2 weeks (Figure 1D). Intrathecal
injectionof theKCC2vector hadnosignificant effect on the tactile
and nociceptive withdrawal thresholds in sham control rats (Fig-
ures 1E and 1F) and on the contralateral (noninjured) hindpaw of
SNL rats (Figure S2). These results indicate that intrathecal KCC2
gene transfer results in profound and enduring elimination of pain
hypersensitivity caused by nerve injury.
Intrathecal KCC2Gene Transfer Induces Efficient KCC2
Expression in Spinal Dorsal Horn and DRG Neurons
Immunocytochemical labeling and confocal microscopy re-
vealed that the KCC2 vector induced transgene expression of
KCC2 throughout the spinal dorsal horn 6 weeks after intrathecal
injection (Figure 2A). We evaluated the in vivo neuronal transduc-
tion efficiency of the lentiviral vector by counting the number of
NeuN (a specific neuronal marker)-positive neurons labeled
with GFP in the spinal dorsal horn. Double immunolabeling
with GFP and NeuN showed that 90% of dorsal horn neurons
in laminas I-III were colocalized with GFP in sham and SNL
rats. Intrathecal injection of the KCC2 vector also resulted in
ectopic KCC2 expression in the DRG. Approximately 94% of
NeuN-positive DRG neurons were colocalized with GFP in
sham and SNL rats (Figure 2B).
The KCC2 protein level in the dorsal spinal cord was signifi-
cantly lower (about 30%) in SNL rats treated with control vectors
compared with that in the sham controls (Figure 2C). Treatment
with the KCC2 vector approximately doubled the amount of
KCC2 proteins in the dorsal spinal cord of SNL rats compared
with control vector-treated rats (Figure 2C). Western blots also
showed that intrathecal injection of the KCC2 vector induced
ectopic KCC2 expression in the DRG of both sham and SNL
rats (Figure 2D). However, intrathecal injection of theKCC2 vector
had no significant effect on the NKCC1 protein levels in the DRG
and dorsal spinal cord (Figure S3). These data indicate that intra-
thecal KCC2 gene transfer is highly efficient to induce sustained
KCC2 expression in the spinal dorsal horn and DRG neurons.
Intrathecal KCC2Gene Transfer Restores KCC2Activity
of Spinal Dorsal Horn Neurons Impaired by Nerve Injury
SNL reduces KCC2 activity by promoting KCC2 protein degra-
dation in the spinal cord (Zhou et al., 2012). We examined1378 Cell Reports 15, 1376–1383, May 17, 2016whether intrathecal injection of the KCC2 vector could restore
KCC2 activity in the spinal dorsal horn of SNL rats 5–6 weeks af-
ter injection. We recorded the reversal potential of GABA-medi-
ated currents (EGABA), which reflects intracellular Cl
 levels (Coull
et al., 2003; Rivera et al., 1999), of dorsal horn neurons in spinal
cord slices. In dorsal horn neurons from sham rats, EGABA was
about 70 mV. In dorsal horn neurons from SNL rats treated
with the control vector, there was a significant depolarizing shift
(about 14 mV) in EGABA (Figures 3A and 3B). Treatment with the
KCC2 vector fully restored EGABA in the spinal dorsal horn neu-
rons of SNL rats (Figures 3A and 3B). These results suggest
that intrathecal injection of the KCC2 vector fully restores nerve
injury-reduced KCC2 activity in spinal dorsal horn neurons.
Intrathecal KCC2 Gene Transfer Reverses the
Depolarizing Shift in EGABA of DRG Neurons Induced by
Nerve Injury
DRG neurons express NKCC1, but not KCC2 (Mao et al., 2012;
Rivera et al., 1999). Nerve injury increases NKCC1 phosphoryla-
tion and causes a depolarizing shift of EGABA in DRG neurons
(Chen et al., 2014a; Mo`dol et al., 2014). Because intrathecal in-
jection of the KCC2 vector induced ectopic KCC2 expression
in DRG neurons, we determined whether this could offset
NKCC1 activity increased by nerve injury in DRG neurons.
DRG neurons are highly heterogeneous, and it was difficult to
ensure that similar sensory neuron phenotypes were sampled
in different groups. We therefore used isolectin B4 (IB4)-Alexa
594 dye, which can label a subgroup of live DRG neurons (Wu
et al., 2004). The EGABA of IB4-positive DRG neurons acutely
dissociated from sham rats treated with control vectors was
26 ± 2.1 mV. SNL caused a significant depolarizing shift in
the EGABA of IB4-positive DRG neurons (Figures 3C and 3D).
Treatment with the KCC2 vector caused a significant hyperpola-
rizing shift (about 10 mV) in the EGABA of IB4-positive DRG neu-
rons from both SNL and sham control rats (Figures 3C and
3D). Our data suggest that induced KCC2 expression effectively
counteracts increased NKCC1 activity to restore Cl homeosta-
sis in injured DRG neurons.
Intrathecal KCC2 Gene Transfer Normalizes Pre- and
Postsynaptic NMDAR Activity Increased by Nerve Injury
in Spinal Cords
Because treatment with the KCC2 vector fully reversed the de-
polarizing shift of EGABA in spinal dorsal horn and DRG neurons
caused by nerve injury and because increased spinal NMDAR
activity is critically involved in the development of neuropathic
pain (Chaplan et al., 1997; Chen et al., 2014c; Sigtermans
et al., 2009), we next examined whether restoring Cl homeosta-
sis via KCC2 gene transfer could reduce the increased spinal
NMDAR activity in SNL rats. We obtained spinal cord slices
from SNL rats 5–6 weeks after intrathecal injection of the control
or KCC2 vector. We measured the postsynaptic NMDAR cur-
rents elicited by puff application of NMDA directly to the re-
corded dorsal horn neuron (Chen et al., 2014b). Treatment with
the KCC2 vector significantly reduced the amplitude of the puff
NMDAR currents of dorsal horn neurons in SNL rats to the level
observed in sham control rats (p < 0.05; Figure 4A). In contrast,
the AMPA receptor current elicited by puff application of AMPA
Figure 2. Transduction Efficiency in Spinal Dorsal Horn and DRG Neurons and KCC2 Expression Levels Induced by Intrathecal KCC2 Vector
(A) Low- and high-magnification confocal images show the distribution of GFP-positive spinal dorsal horn neurons (labeled with NeuN) in sham and SNL rats
6 weeks after intrathecal injection of the KCC2-GFP vector.
(B) Confocal images show the distribution of GFP-positive DRG neurons (labeled with NeuN) of sham and SNL rats treated with the intrathecal KCC2-GFP vector.
(C) Original gel images and quantification data show the protein level of KCC2 (140 kDa) in the dorsal spinal cords of sham and SNL rats 2, 4, and 6 weeks after
intrathecal injection of the KCC2 (n = 6 samples from 6 rats in each group) or control (n = 6 samples from 6 rats in each group) vector (***p < 0.001 compared with
control vector-treated sham rats, and #p < 0.05 compared with control vector-treated sham rats) (two-way ANOVA analysis with Tukey’s post hoc test). The data
are presented as means ± SEM.
(D) Original gel images and quantification data show ectopic KCC2 expression in the DRG of sham and SNL rats treated with the KCC2 or control vector 2, 4, and
6weeks after intrathecal injection (n = 6 samples from 6 rats in each group). The red triangle indicates the KCC2 band position. GAPDH (40 kDa) was included as
a protein loading control. The data are presented as means ± SEM.to dorsal horn neurons did not differ significantly between KCC2
vector- and control vector-treated SNL rats (Figure 4A).
Presynaptic NMDARs are not functionally active in the normal
spinal dorsal horn. However, in the chronic pain condition, pre-synaptic NMDAR activity is increased, facilitating glutamate
release from primary afferent terminals (Chen et al., 2014b).
Because intrathecal KCC2 gene transfer induced KCC2 expres-
sion in DRG neurons, we determined whether this treatment alsoCell Reports 15, 1376–1383, May 17, 2016 1379
Figure 3. Intrathecal KCC2 Gene Transfer Restores EGABA in Spinal Dorsal Horn Neurons and DRG Neurons of SNL Rats
(A) Original traces of currents elicited by puff AMAP (holding potentials from90mV to50mV) to dorsal horn neurons of sham andSNL rats treatedwith KCC2 or
control vector.
(B) Mean current-voltage plots and summary data show the EGABA of spinal dorsal horn neurons from sham and SNL rats 56 weeks after treatment with the
KCC2 (sham, n = 11 neurons and SNL, n = 12 neurons) or control (sham, n = 12 neurons and SNL, n = 12 neurons) vector (*p < 0.05 compared with sham rats
treated with control vector, and #p < 0.05 compared with sham rats treated with control vector) (one-way ANOVA analysis followed by Tukey’s post hoc test).
(C) Representative traces of GABA-elicited currents (holding potentials are shown on the left) in DRG neurons from sham or SNL rats treated with KCC2 or control
vector.
(D) Mean current-voltage plots and summary EGABA data in DRG neurons from sham or SNL rats 56 weeks after treatment with the KCC2 (sham, n = 9 neurons
and SNL, n = 10 neurons) or control (sham, n = 8 neurons and SNL, n = 7 neurons) vector (*p < 0.05 compared with sham rats treated with control vector, and #p <
0.05 comparedwith sham rats treatedwith control vector) (one-way ANOVA analysis followed by Tukey’s post hoc test). The data are presented asmeans ±SEM.altered presynaptic NMDAR activity in the spinal dorsal horn. We
recorded miniature excitatory postsynaptic currents (mEPSCs),
which reflect quantal glutamate release from presynaptic termi-
nals (Chen et al., 2014b). In the dorsal horn neurons of control
vector-treated SNL rats, bath application of (2R)-amino-5-phos-
phonopentanoate (AP5), a specific NMDAR antagonist, rapidly
reduced the frequency, but not the amplitude, of mEPSCs (Fig-
ures 4B and 4C). In the dorsal horn neurons recorded from
KCC2 vector-treated SNL rats, the frequency of mEPSCs was
significantly lower than that observed in control vector-treated
SNL rats. Furthermore, AP5 application had no significant effects
on the frequency or amplitude of mEPSCs in dorsal horn neurons
from KCC2 vector-treated SNL rats (Figures 4B and 4C).
In addition, we recorded EPSCs monosynaptically evoked by
stimulation of the dorsal root, reflecting glutamate release from
primary afferent terminals (Chen et al., 2014b; Li et al., 2002).
In the dorsal horn neurons from control vector-treated SNL
rats, bath application of AP5 significantly reduced the amplitude1380 Cell Reports 15, 1376–1383, May 17, 2016of the evoked EPSCs (Figure 4D). However, in the dorsal horn
neurons from KCC2 vector-treated SNL rats, AP5 had no signif-
icant effect on the amplitude of evoked EPSCs (Figure 4D).
Consistent with the lack of an effect of KCC2 overexpression
on tactile and nociceptive thresholds in sham rats, KCC2 vector
injection produced no effect on pre- or postsynaptic NMDAR ac-
tivity of spinal dorsal horn neurons in sham rats (Figures S4A–
S4D). Together, these results indicate that restoring Cl homeo-
stasis by increasing KCC2 expression normalizes both pre- and
postsynaptic NMDAR activity increased by nerve injury in the
spinal dorsal horn.
DISCUSSION
Our study shows that lentiviral vector-mediated KCC2 gene
transfer via intrathecal injection has a profound and long-lasting
effect on pain hypersensitivity caused by nerve injury. Such a
dramatic effect is likely due to the ability of lentiviral vectors to
Figure 4. Intrathecal KCC2 Gene Transfer
Normalizes Synaptic NMDAR Activity in
the Spinal Dorsal Horn of SNL Rats
(A) Original current traces and summary data show
currents elicited by puff application of 100 mM
NMDA or 20 mM AMPA to spinal dorsal horn neu-
rons in sham (n = 12 neurons), control vector-
treated (n = 16 neurons), or KCC2 vector-treated
(n = 18 neurons) SNL rats 56 weeks after injection
(*p < 0.05 compared with sham group) (one-way
ANOVA analysis followed by Tukey’s post hoc test).
(B) Representative recording traces and cumula-
tive plots show mEPSCs of spinal dorsal horn
neurons recorded from control vector-treated or
KCC2 vector-treated SNL rats before (baseline),
with (AP5), and after (washout) bath application of
50 mM AP5.
(C) Summary data show baseline values and the
AP5 effect on the frequency and amplitude of
mEPSCs of spinal dorsal neurons from control
vector-treated (n = 8 neurons) or KCC2 vector-
treated (n = 9 neurons) SNL rats (*p < 0.05
compared with the baseline value, and #p < 0.05
compared with the baseline value in the control
vector-treated group) (one-way ANOVA analysis
followed by Tukey’s post hoc test).
(D) Original recording traces and mean data show
the AP5 effect on the amplitude of EPSCs of spinal
dorsal horn neurons monosynaptically evoked
from stimulation of the dorsal root in control vec-
tor-treated (n = 11 neurons) or KCC2 vector-
treated (n = 12 neurons) SNL rats 56 weeks after
injection (*p < 0.05 compared with the baseline
value, and #p < 0.05 compared with the baseline
value in the control vector-treated group) (one-
way ANOVA analysis followed by Tukey’s post hoc
test). The data are presented as means ± SEM.induce expression of KCC2 in both dorsal horn andDRGneurons
and thereby restore the balance of synaptic inhibition and exci-
tation at both pre- and postsynaptic sites. Our electrophysiolog-
ical data confirm that induced KCC2 expression effectively
restored Cl homeostasis in both spinal dorsal horn and DRG
neurons. Although NKCC1 inhibitors and KCC2 enhancers pro-
duce short-acting effects on neuropathic pain (Cramer et al.,
2008; Lavertu et al., 2014), these agents do not have the ability
to persistently restore Cl homeostasis in the spinal dorsal
horn and DRG neurons that is disrupted in neuropathic pain.
Compared to these drug treatments, intrathecal gene delivery
could more directly target abnormal chronic pain signaling in a
tissue-specific manner (Storek et al., 2008). Also, gene therapy
could provide sustained long-term analgesia without the need
for repeated administrations, making it particularly suitable for
treating chronic pain. Interestingly, we found a distinct time
course for the reversal of mechanical hyperalgesia and tactile al-Cell Rlodynia after intrathecal injection of the
KCC2 vector. Mechanical hyperalgesia
induced by SNL was fully reversed by
KCC2 gene transfer within 2 weeks, but
the effect of gene transfer on tactile allo-
dynia was more gradual, taking severalweeks to achieve the maximum effect. It is possible that the
KCC2 vector may initially transduce more high-threshold noci-
ceptive than low-threshold sensory neurons, which could
explain its more rapid effect on hyperalgesia than on allodynia.
Because intrathecal injection via lumbar puncture is a commonly
used and minimally invasive clinical procedure, our findings
represent a proof of principle that this therapeutic strategy can
potentially be used to treat patients with intractable neuropathic
pain and other neurological disorders associated with reduced
KCC2 activity, such as epilepsy and spasticity (Boulenguez
et al., 2010; Palma et al., 2006).
Fast synaptic inhibition by GABA and glycine is essential for
physiological processing of nociceptive transmission in the spi-
nal dorsal horn. Although a loss of synaptic inhibition has been
found in many neuropathic pain conditions (Boulenguez et al.,
2010; Chen et al., 2014d; Coull et al., 2003; Jolivalt et al., 2008;
Zhou et al., 2012), it remains unclear to what extent impairedeports 15, 1376–1383, May 17, 2016 1381
Cl homeostasis sustains chronic neuropathic pain. Our study,
by inducing KCC2 overexpression, indicates that disrupted Cl
homeostasis contributes critically to synaptic disinhibition and
chronic pain caused by nerve injury. The spinal dorsal horn neu-
rons are highly heterogeneous, and it would be interesting to
further study the effect of expressing KCC2 specifically in a sub-
population (either excitatory or inhibitory) of dorsal horn neurons
on neuropathic pain.
DRG neurons, and possibly their central terminals, normally
maintain a relatively high Cl level via NKCC1 (Sung et al.,
2000), a requirement for presynaptic inhibition (Rudomin and
Schmidt, 1999). Presynaptic GABAA receptor activation, which
is produced by the release of GABA from spinal interneurons, in-
hibits glutamatergic input from primary afferents to dorsal horn
neurons (Yuan et al., 2009). In this study, we demonstrated
that nerve injury induced a depolarizing shift of EGABA in DRG
neurons and that intrathecal KCC2 gene transfer completely
reversed this depolarizing shift. Thus, we conclude that ectopic
KCC2 expression counteracts NKCC1 activity to restore presyn-
aptic inhibition, which may contribute to the powerful and sus-
tained effect of KCC2 gene transfer on neuropathic pain.
Another striking finding of our study is that intrathecal KCC2
gene transfer completely reversed pre- and postsynaptic
NMDAR activity of spinal dorsal horn neurons potentiated by
nerve injury, indicating that Cl homeostasis mediates a cross-
talk between synaptic inhibition and excitation. Increased
NMDAR activity in the spinal dorsal horn causes central sensiti-
zation and represents a key mechanism of neuropathic pain
(Chaplan et al., 1997; Chen et al., 2014b, 2014c). Diminished
synaptic inhibition and augmented NMDAR activation in neuro-
pathic pain have been recognized as separate phenomena,
and their reciprocal relationship is unclear. We have previously
shown that spinal NMDAR activity increased by nerve injury pro-
motes KCC2 degradation through calpain activation to diminish
synaptic inhibition (Zhou et al., 2012). On the other hand, block-
ing GABAA and glycine receptors at the spinal cord level can
cause pain hypersensitivity, which can be blocked by NMDAR
antagonists (Cao et al., 2011; Yamamoto and Yaksh, 1993).
Our findings provide direct evidence for the critical role of
impaired Cl homeostasis in increased spinal NMDAR activation
induced by nerve injury. Both pre- and postsynaptic NMDAR ac-
tivity in spinal dorsal horn and DRG neurons may be large, but
latent, held in check by Cl-dependent synaptic inhibition. Our
study reveals that Cl homeostasis plays a critical role in the
reciprocal relationship between synaptic inhibition and NMDAR
activity and that an imbalance in this relationship likely initiates
a vicious cycle that sustains chronic neuropathic pain. The com-
plete reversal of postsynaptic NMDAR activity in the spinal dor-
sal horn and presynaptic NMDAR activity at primary afferent ter-
minals likely accounts for the potent and persistent effect of
induced KCC2 expression on neuropathic pain. Nevertheless,
it is unclear exactly how restoring Cl homeostasis normalizes
nerve injury-induced potentiation of synaptic NMDAR activity.
Because there is no evidence for a direct interaction between
KCC2 and NMDARs, we postulate that KCC2 overexpression-
induced suppression of pre- and postsynaptic NMDAR activity
in neuropathic pain probably results from the reduced excit-
ability of DRG and spinal dorsal horn neurons.1382 Cell Reports 15, 1376–1383, May 17, 2016In summary, we found that intrathecal KCC2 gene delivery
produces complete and long-lasting relief from nerve injury-
induced neuropathic pain by restoring Cl homeostasis in
spinal dorsal horn and DRG neurons. Our findings also
indicate that nerve injury increases pre- and postsynaptic
NMDAR activity at the spinal cord level by disrupting Cl ho-
meostasis. This information significantly advances our under-
standing of homeostatic synaptic plasticity and provides a
promising gene therapy strategy for treating intractable neuro-
pathic pain.
EXPERIMENTAL PROCEDURES
Viral Vector Constructs
The full-length coding sequence of GFP or rat KCC2 was cloned into the lenti-
viral vector pLenti6/V5-DEST. The viral vector preparation is described in
detail in the Supplemental Information.
Rat Model of Neuropathic Pain and Behavioral Assessments of
Nociception
Adult male Sprague-Dawley rats (9–10 weeks old) were used for this study. All
of the experimental procedures were approved by the Animal Care and Use
Committee of The University of Texas MD Anderson Cancer Center. SNL
and intrathecal injections were performed as previously described (Chen
et al., 2014b; Kim and Chung, 1992). Tactile allodynia was tested using von
Frey filaments and the ‘‘up-down’’ method (Chaplan et al., 1994). Themechan-
ical nociceptive threshold was tested using a noxious pressure stimulus as
previously described (Chen et al., 2014b; Zhou et al., 2012). See Supplemental
Information for details.
Western Blotting and Immunocytochemistry
Western blotting and immunocytochemical labeling were performed using
standard methods described in Supplemental Information.
Electrophysiological Recordings
Lumbar spinal cord slices were prepared from rats as described previously (Li
et al., 2002; Zhou et al., 2012). Spinal dorsal horn neurons were visualized and
selected for whole-cell recording of NMDAR activity. We used the Cl-imper-
meable gramicidin-perforated recording method to record EGABA of spinal dor-
sal horn and DRG neurons, as described previously (Chen et al., 2014b; Sung
et al., 2000). Details are provided in Supplemental Information.
Statistical Analysis
Results are expressed as means ± SEM. The behavioral and biochemical data
were analyzed using two-way ANOVA analysis with Tukey’s post hoc test. The
electrophysiological data were analyzed using one-way ANOVA analysis with
Tukey’s post hoc test. p < 0.05 was considered statistically significant. See
Supplemental Information for details.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and four figures and can be found with this article online at http://dx.doi.org/
10.1016/j.celrep.2016.04.039.
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